STOCK TITAN

LataMed AI Corp. (LMED) returns to permanent LMED ticker after stock split

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

LataMed AI Corp. reports that, effective August 11, 2026, its common stock resumed trading under its permanent trading symbol “LMED”. This follows the expiration of the temporary symbol “LMEDD”, which had been used in connection with the company’s previously announced five-for-one (5-for-1) forward stock split. The common stock continues to trade on the OTC Markets under the LMED symbol.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Forward stock split ratio 5-for-1 Previously announced forward stock split associated with temporary symbol LMEDD
Effective date of symbol reversion August 11, 2026 Date trading resumed under permanent symbol LMED
forward stock split financial
"previously announced five-for-one (5-for-1) forward stock split"
A forward stock split is when a company increases the number of its shares by dividing each existing share into smaller parts. This makes the stock price lower and more affordable for investors, similar to splitting a pizza into more slices so everyone can get a smaller piece. It doesn't change the company's total value, just how it's divided among shareholders.
temporary trading symbol market
"expiration of the temporary trading symbol “LMEDD,” which had been assigned"
OTC Markets market
"common stock will continue to trade on the OTC Markets under the symbol LMED"
Over-the-counter (OTC) markets are trading venues where buyers and sellers deal directly through dealers or electronic networks instead of on a formal exchange; think of a neighborhood flea market versus a supermarket. They matter to investors because OTC-listed stocks often represent smaller or international companies with fewer reporting requirements, which can mean lower liquidity, wider price swings and higher risk but sometimes earlier access to growth opportunities.

FAQ

What did LMED disclose in this Form 8-K filing?

LataMed AI Corp. disclosed that, effective August 11, 2026, its common stock resumed trading under its permanent symbol LMED on the OTC Markets, replacing the temporary symbol LMEDD used after a prior 5-for-1 forward stock split.

What is the current trading symbol for LataMed AI Corp. (LMED)?

The current trading symbol for LataMed AI Corp. is LMED. The company stated that its common stock resumed trading under this permanent symbol on August 11, 2026, after the temporary symbol LMEDD expired following a forward stock split.

On which market does LataMed AI Corp. (LMED) trade after the symbol change?

LataMed AI Corp.’s common stock continues to trade on the OTC Markets. The company confirmed that, effective August 11, 2026, the permanent trading symbol is LMED, replacing the temporary post-split symbol LMEDD.

Why was LMEDD used as a temporary trading symbol for LMED?

The temporary symbol LMEDD was used in connection with LataMed AI Corp.’s previously announced five-for-one (5-for-1) forward stock split. After this temporary period ended, the company’s stock resumed trading under its permanent symbol LMED.

Did LataMed AI Corp. (LMED) announce any new financial results in this filing?

No new financial results were presented. The disclosure focused on the trading symbol transition, stating that, effective August 11, 2026, the common stock now trades under permanent symbol LMED on the OTC Markets after use of temporary symbol LMEDD.

Does the symbol change affect the 5-for-1 forward stock split for LMED?

The company referenced a prior 5-for-1 forward stock split that led to the temporary symbol LMEDD. This filing only states that trading has resumed under LMED; it does not alter or restate the previously announced stock split terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 11, 2026

 

LATAMED AI CORP.

(Exact name of registrant as specified in its charter)

 

  Nevada

 

000-56634

 

26-3670551

(State or other jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

Av. Rómulo Gallegos con Av. Las Palmas

Edif. Torre Gerencial Los Andes

Caracas 1071, Venezuela

(Address of principal executive offices, including zip code.)

 

+1 787 476 2350

(Telephone number, including area code)

 

Catalyst Crew Technologies Corp.

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Item 8.01 Other Events.

 

Effective August 11, 2026, LataMed AI Corp. (the “Company”) resumed trading under its permanent trading symbol “LMED” following the expiration of the temporary trading symbol “LMEDD,” which had been assigned in connection with the Company’s previously announced five-for-one (5-for-1) forward stock split.

 

The Company’s common stock will continue to trade on the OTC Markets under the symbol LMED.

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

LATAMED AI CORP.

 

 

 

 

Dated: August 11, 2026

By:

/s/ Kevin Rodan Levy

 

 

Kevin Rodan Levy

 

 

 

Chief Executive Officer

 

 

 

3

 

Filing Exhibits & Attachments

5 documents